get a key
steadybase-$ company ANGO
account_id none on file
legal_name Angiodynamics Inc
ticker ANGO
cik 1275187
domain angiodynamics.com
entry_point_account_id none on file
name AngioDynamics Inc.
exchange Nasdaq
sector Health Care
hq Latham, NY, United States
calls 6 filings 2 executives 6 family 0
why_nownone on file
calls
This year-over-year improvement is largely attributable to our revenue growth and the success of our expense management initiatives, very similar to the story for the quarter.

Jul 15, 2025 / receipt, needs a key / Jim Clemmer, CEO | earnings call 2025-07-15 | transcript 3bdd6a98-aad3-4047-b7b6-73cc43c95611 | chars 24584-24759 | segment 24

Yeah, so, you know, we talked about before having about, you know, 40 field-based salespeople, including our territory managers and regional managers. That's kind of where we ended the second quarter. You know, to support that, we also have clinical specialists and per diems. you know, another 30 field-based reps that are supporting the - or field-based people that are supporting our reps too. So all in all, you know, we've got about 74 field-based Arian employees today. That will probably be a little bit more as we head into the back half of the year, but I think we've done a good job, you know, preparing that team for the growth that we're expecting for this year.

Jan 6, 2022 / receipt, needs a key / Jim, other | earnings call 2022-01-06 | transcript 45e7eea8-dbd3-46d2-9df4-77f220c94c41 | chars 47171-47845 | segment 48

In the near term, we anticipate maintaining our disciplined approach to capital allocation and expense management.

Mar 30, 2021 / receipt, needs a key / Jim Clemmer, CEO | earnings call 2021-03-30 | transcript 9ce0e35d-65af-4481-9bc3-3be7967d524f | chars 7355-7469 | segment 7

We expect travel costs, along with our ongoing investments in the sales organization, to increase into FY22 as the global environment improves, which will drive incremental expenses in 22.

Mar 30, 2021 / receipt, needs a key / Steve, CFO | earnings call 2021-03-30 | transcript 9ce0e35d-65af-4481-9bc3-3be7967d524f | chars 15730-15918 | segment 15

Additionally, we continue to balance near-term cash and expense management with strategic investment in our long-term growth initiatives, and we're pleased to deliver an adjusted EPS of one cent for the second quarter.

Jan 7, 2021 / receipt, needs a key / Jim Clemmer, CEO | earnings call 2021-01-07 | transcript 7dafdf71-b0ad-4d5e-98b6-1ff5d7e0d9f3 | chars 2596-2814 | segment 2

You know, it'll be a moderate increase, but the reason we're able to get there while we're balancing the increased investments that we want to have in areas like Angie Vacari on a nanoknife is what we talked about through this COVID pandemic and some of the levers we've been able to pull, making sure we're cutting back on discretionary spending and Clearly across the board, travel and entertainment isn't happening as much as it used to in the past. So we've got some areas where we can definitely tighten down expenses while maintaining the proper investments and growth.

Sep 29, 2020 / receipt, needs a key / Jim, CEO | earnings call 2020-09-29 | transcript c05998e0-5381-4234-bb73-37ba8da118b8 | chars 22501-23076 | segment 22

filings
Medical Receptionist | {"ats": "smartrecruiters", "city": "Baltimore", "state": "MD", "job_id": "99340124", "remote": false, "category": "other", "function": "clinical", "location": "Baltimore, MD, Un

company_statement / Oct 1, 2016 / receipt

Customer Service | {"ats": "smartrecruiters", "city": "Minneapolis", "state": "MN", "job_id": "99340185", "remote": false, "category": "other", "function": "other", "location": "Minneapolis, MN, Unite

company_statement / Oct 1, 2016 / receipt

executives
Eileen Auen director - receipt
George W. Bourne Senior Vice President - receipt
James C. Clemmer President and Chief Executive Officer - receipt
Jim Clemmer CEO - receipt
Joseph M. DeVivo President and Chief Executive Officer - receipt
Steve Trowbridge Executive Vice President and Chief Financial Officer - receipt
familynone on file
upcoming
2026-10-08 earnings call scheduled ir
changes
2020-08-14 director, retiring sec_8k
2017-04-12 director, departed sec_8k
2016-11-10 director, appointed sec_8k
2016-08-05 director, departed sec_8k
2016-04-06 President and Chief Executive Officer, appointed sec_8k
2012-12-17 Senior Vice President, appointed sec_8k
2012-12-17 Senior Vice President, departed sec_8k
2012-05-25 director, appointed sec_8k
2011-09-22 Senior Vice President and Chief Technology Officer, departed sec_8k
2011-08-16 President and Chief Executive Officer, appointed sec_8k
mcp_package_hint
steadybase-$